U.S. Markets open in 4 hrs 20 mins
  • S&P Futures

    3,251.50
    -50.75 (-1.54%)
     
  • Dow Futures

    26,147.00
    -410.00 (-1.54%)
     
  • Nasdaq Futures

    11,112.50
    -230.25 (-2.03%)
     
  • Russell 2000 Futures

    1,539.70
    -18.70 (-1.20%)
     
  • Crude Oil

    36.22
    +0.05 (+0.14%)
     
  • Gold

    1,869.30
    +1.30 (+0.07%)
     
  • Silver

    23.34
    -0.02 (-0.09%)
     
  • EUR/USD

    1.1680
    +0.0001 (+0.0117%)
     
  • 10-Yr Bond

    0.8350
    0.0000 (0.00%)
     
  • Vix

    39.66
    -0.62 (-1.54%)
     
  • GBP/USD

    1.2930
    +0.0007 (+0.0530%)
     
  • USD/JPY

    104.3140
    -0.2960 (-0.2830%)
     
  • BTC-USD

    13,214.24
    -159.94 (-1.20%)
     
  • CMC Crypto 200

    258.71
    +16.03 (+6.61%)
     
  • FTSE 100

    5,558.90
    -22.85 (-0.41%)
     
  • Nikkei 225

    22,977.13
    -354.81 (-1.52%)
     

Kiniksa Pharmaceuticals (KNSA) Chairman & CEO Sanj K Patel Sold $5.3 million of Shares

GuruFocus.com
·1 min read

- By insider

Chairman & CEO of Kiniksa Pharmaceuticals (30-Year Financial, Insider Trades) Sanj K Patel (insider trades) sold 251,572 shares of KNSA on 10/12/2020 at an average price of $21.02 a share. The total sale was $5.3 million.


Kiniksa Pharmaceuticals Ltd has a market cap of $1.32 billion; its shares were traded at around $19.41 .

CEO Recent Trades:

  • Chairman & CEO Sanj K Patel sold 251,572 shares of KNSA stock on 10/12/2020 at the average price of $21.02. The price of the stock has decreased by 7.66% since.

For the complete insider trading history of KNSA, click here

.This article first appeared on GuruFocus.